PSA test valuable in predicting biopsy need, low-risk prostate cancer, study finds
Friday, October 21, 2011 - 21:30
in Health & Medicine
The prostate-specific antigen test, commonly known as the PSA test, is valuable in predicting which men should have biopsies and which are likely to be diagnosed with low-risk prostate cancer, a new study has found.